Health BioNTech Settles mRNA Patent Dispute, Payouts Confirmed for GSK and CureVac BioNTech has reached a significant settlement in its three-year mRNA patent dispute with GSK and CureVac, a fellow German biotechnology firm that BioNTech is... Editorial6 hours ago